Publications

Division/Center

Who Owns Sepsis?

Ann. Intern. Med.
Klompas M, Osborn TM, Rhee C

Improving measurement of binary covariates in claims data: A simulation study.

Pharmacoepidemiol Drug Saf
Connolly JG, Glynn RJ, Schneeweiss S, Gagne JJ

Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy.

J Pain Res
Esposito DB, Cepeda MS, Holick CN, Knox C, Desai VC, Liu N, Vojjala SK, Lyons JG, Wedin GP, Lanes S,

The Limited Utility of Ranking Hospitals Based on Their Colon Surgery Infection Rates.

Clin. Infect. Dis.
Caroff DA, Wang R, Zhang Z, Wolf R, Septimus E, Harris AD, Jackson SS, Poland RE, Hickok J, Huang SS, Platt R

Considerations for using distributed research networks to conduct aspects of randomized trials.

Contemp Clin Trials Commun
Marsolo KA, Brown JS, Hernandez AF, Hammill BG, Raman SR, Syat B, Platt R, Curtis LH

Improvements in Sepsis-Associated Mortality in Hospitalized Cancer vs Non-Cancer Patients: A 12-Year Analysis Using Clinical Data.

Ann Am Thorac Soc
Cooper AJ, Keller S, Chan C, Glotzbecker BE, Klompas M, Baron RM, Rhee C,

Quantifying how small variations in design elements affect risk in an incident cohort study in claims.

Pharmacoepidemiol Drug Saf
Izem R, Huang TY, Hou L, Pestine E, Nguyen M, Maro JC

Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.

Medicine (Baltimore)
Guadamuz JS, Ozenberger K, Qato DM, Ko NY, Saffore CD, Adimadhyam S, Cha AS, Moran KM, Sweiss K, Patel PR, Chiu BC, Calip GS

Evaluating the impact of increasing allowable inpatient diagnoses in Medicare claims data.

Epidemiology
Connolly JG, Gagne JJ, Lin KJ

Privacy-protecting multivariable-adjusted distributed regression analysis for multi-center pediatric study.

Pediatr. Res.
Toh S, Rifas-Shiman SL, Lin PI, Bailey LC, Forrest CB, Horgan CE, Lunsford D, Moyneur E, Sturtevant JL, Young JG, Block JP,

Risk Adjustment for Sepsis Mortality to Facilitate Hospital Comparisons Using Centers for Disease Control and Prevention's Adult Sepsis Event Criteria and Routine Electronic Clinical Data.

Crit Care Explor
Rhee C, Wang R, Song Y, Zhang Z, Kadri SS, Septimus EJ, Fram D, Jin R, Poland RE, Hickok J, Sands K, Klompas M.

Passive immunity for the treatment of influenza: quality not quantity

Lancet Respir Med
Kanjilal S, Mina MJ

Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety

Drug Saf
Wang SV, Patterson OV, Gagne JJ, Brown JS, Ball R, Jonsson P, Wright A, Zhou L, Goettsch W, Bate A

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV

Sex Transm Infect
Hojilla JC, Marcus J, Volk JE, Leyden W, Hare CB, Hechter RC, Edelman EJ, Silverberg M, Satre DD

Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data

Support Care Cancer
Gewandter JS, Kleckner AS, Marshall JH, Brown JS, Curtis LH, Bautista J, Dworkin RH, Kleckner IR, Kolb N, Mohile SG, Mustian KM

Identification of potential drug name confusion errors in the Sentinel System.

Pharmacoepidemiol Drug Saf
Cocoros NM, Haynes K, Her Q, Cosgrove A, Dee E, Lin ND, Tu CM, Ding Y, Nguyen M, Toh S

Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study

Pharmacotherapy
Lee I, Adimadhyam S, Nutescu EA, Zhou J, Asfaw AA, Sweiss KI, Patel PR, Calip GS

Electronic Health Record Use in Public Health Infectious Disease Surveillance, USA, 2018-2019.

Curr Infect Dis Rep
Willis SJ, Cocoros NM, Randall LM, Ochoa AM, Haney G, Hsu KK, DeMaria A, Klompas M

Bystander Ethics and Good Samaritanism: A Paradox for Learning Health Organizations.

Hastings Cent Rep
Sabin JE, Cocoros NM, Garcia CJ, Goldsack JC, Haynes K, Lin ND, McCall D, Nair V, Pokorney SD, McMahill-Walraven CN, Granger CB, Platt R

Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus.

J Manag Care Spec Pharm
Kent DJ, McMahill-Walraven CN, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM